Of importance, they demonstrated that CD31+/VEGFR2+/CD45− endothelial cells were the main source of type I IFN and antitumour immunity response in the murine model of melanoma and ex vivo model of human melanoma cells [117]. Here, PECAM1 is linked to melanoma.